Fuji Pharmaceutical Co., Ltd. Revises Dividend Forecast — Annual Dividend Up 4.26%
Fuji Pharmaceutical Co., Ltd. (TSE:45540) has revised its dividend forecast for the 2026 fiscal year, increasing both its annual and interim dividend payments.
| Item | Before | After | Change |
|---|---|---|---|
| Annual Dividend (JPY per share) | JPY 47.00 | JPY 49.00 | +JPY 2.00 (4.26%) |
| Interim Dividend (JPY per share) | JPY 21.00 | JPY 23.00 | +JPY 2.00 (9.52%) |
The company cited its commitment to stable and continuous shareholder returns as the reason for the revision. It aims to maintain a dividend payout ratio of around 30% based on operating profit, and continues to adopt a progressive dividend policy. Management noted that sales of its key products have progressed smoothly, and after carefully reviewing financial soundness, it adjusted the interim dividend forecast.
The revision reflects Fuji Pharmaceutical's intention to balance financial health with ongoing shareholder returns. The increase in interim dividends may signal confidence in the company's future earnings stability and the sustainability of its dividend policy. Investors may view this as a positive sign of the company's long-term financial strategy.
Source: Original filing (TDnet) | 日本語版
This article is for informational purposes only and does not constitute investment advice. Always verify against the original filing.